Only therapeutic has shown efficacy at stage2 is Zyesami.
Molnupiravir a nice tool in the tool box for stage 1 COVID-19. Problem is in stage 2 , the non replication stage day 10 ( virus is not replicating) is the most dangerous and destructive stage. The attack is directed at the alveolar 2 . Only therapeutic that has shown efficacy at this stage is Zyesami. $ nrxp. Let’s go FDA !! Continue to be optimistic about MRK! 😃 $Merck(MRK)$
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
点赞
举报
登录后可参与评论
暂无评论